Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1) (Middle Region) Peptide
AREL1
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits AREL1
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-KIAA0317 antibody (Catalog #: ARP44875_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
- Synonymes
- KIAA0317 Peptide, apoptosis resistant E3 ubiquitin protein ligase 1 Peptide, AREL1 Peptide
- Sujet
-
KIAA0317 contains 1 filamin repeat and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. The exact function of KIAA0317 remains unknown.
Alias Symbols: KIAA0317,
Protein Size: 823 - Poids moléculaire
- 94 kDa
- ID gène
- 9870
- NCBI Accession
- NM_001039479, NP_001034568
- UniProt
- O15033
-
Vous êtes ici:
